← back to search

Marlene Hechtner

Boehringer Ingelheim (Germany) · DE
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Cancer survivorship and care, Genetic factors in colorectal cancer, BRCA gene mutations in cancer, and Global Cancer Incidence and Screening.
h-index
20
citations
1,200
works
58
NIH funding
primary concept
email

Recent publications

“That was a tip from my physician”—Gender‐specific pathways of patients and relatives to outpatient psychosocial cancer counselling centres—A qualitative study
Psycho-Oncology 2022cited by 12position: middledoi
Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis
International Journal of COPD 2022cited by 11position: middledoi
Costs and Clinical Consequences of Compliance with COPD GOLD Recommendations or National Guidelines Compared with Current Clinical Practice in Belgium, Germany, Sweden, and the United States
International Journal of COPD 2022cited by 8position: middledoi
What is the best time for psychosocial counselling from the perspective of cancer patients and their relatives? A multi‐centre qualitative study
Counselling and Psychotherapy Research 2021cited by 8position: middledoi
Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study
The Lancet Oncology 2020cited by 51position: middledoi
Quality of life after pulmonary stereotactic fractionated radiotherapy (SBRT): Results of the phase II STRIPE trial
Radiotherapy and Oncology 2020cited by 38position: middledoi
Returning to work in lung cancer survivors—a multi-center cross-sectional study in Germany
Supportive Care in Cancer 2020cited by 29position: middledoi
Was Männer davon abhält, ambulante Krebsberatungsstellen aufzusuchen. Eine qualitative Studie
Der Onkologe 2020cited by 27position: middledoi
Use of psychosocial services by lung cancer survivors in Germany
Strahlentherapie und Onkologie 2019cited by 12position: middledoi
P2.17-19 Quality of Life After Pulmonary Stereotactic Fractionated Radiotherapy: Longterm Results of the Phase II STRIPE Trial
Journal of Thoracic Oncology 2019cited by 1position: middledoi
Quality of Life in NSCLC Survivors — A Multicenter Cross-Sectional Study
Journal of Thoracic Oncology 2018cited by 85position: firstdoi
Psychological distress in lung cancer survivors at least 1 year after diagnosis—Results of a German multicenter cross‐sectional study
Psycho-Oncology 2018cited by 38position: middledoi
Early Impact of Pulmonary Fractionated Stereotactic Body Radiotherapy on Quality of Life:Benefit for Patients With Low Initial Scores (STRIPE Trial)
Journal of Thoracic Oncology 2018cited by 23position: middledoi
Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation
Journal of Clinical Epidemiology 2018cited by 14position: middledoi
Craniofacial venous malformations treated by percutaneous sclerotherapy using polidocanol: a single-center experience
Acta Radiologica 2018cited by 13position: middledoi
Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting
Journal of Neuro-Oncology 2017cited by 56position: middledoi
Incidence of Heterotopic Ossification in Minimally Invasive Short-Stem THA using the Modified Anterolateral Approach
Hip International 2017cited by 30position: middledoi
The learning curve in short-stem THA: influence of the surgeon’s experience on intraoperative adjustments due to intraoperative radiography
European Journal of Orthopaedic Surgery & Traumatology 2017cited by 30position: middledoi
Compliance with patient-reported outcome assessment in glioma patients: predictors for drop out
Neuro-Oncology Practice 2017cited by 26position: middledoi
Long-term quality of life in inoperable non-small cell lung cancer patients treated with conventionally fractionated compared to hyperfractionated accelerated radiotherapy – Results of the randomized CHARTWEL trial
Radiotherapy and Oncology 2017cited by 8position: firstdoi
Psychische Verfassung und psychosoziale Versorgungssituation von Überlebenden von kleinzelligem Lungenkrebs
Der Onkologe 2017cited by 6position: middledoi
Utilization of colonoscopy and colonoscopic findings among individuals aged 40–54 years with a positive family history of colorectal cancer: a cross-sectional study in general practice
European Journal of Cancer Prevention 2017cited by 2position: middledoi
Lebensqualität und psychosoziale Rehabilitation bei Lungenkrebsüberlebenden (LARIS) – eine multizentrische Studie
Pneumologie 2017cited by 0position: firstdoi
Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting
Journal of Neuro-Oncology 2016cited by 41position: middledoi
Endovascular treatment of head and neck arteriovenous malformations: long-term angiographic and quality of life results
Journal of NeuroInterventional Surgery 2016cited by 35position: middledoi
Assessing psychological and supportive care needs in glioma patients - feasibility study on the use of the Supportive Care Needs Survey Short Form (SCNS-SF34-G) and the Supportive Care Needs Survey Screening Tool (SCNS-ST9) in clinical practice
European Journal of Cancer Care 2016cited by 31position: lastdoi
Endovascular therapy for vasospasm after aneurysmatic subarachnoid hemorrhage
British Journal of Neurosurgery 2016cited by 21position: middledoi
Frequency of a positive family history of colorectal cancer in general practice: a cross-sectional study
Family Practice 2016cited by 10position: middledoi
Effectiveness of maxillary protraction using facemask with or without maxillary expansion: a systematic review and meta-analysis
Clinical Oral Investigations 2015cited by 95position: middledoi
Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study
BMC Cancer 2015cited by 5position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Susanne Singer · University Medical Center Freiburg15 papers (2014–2022)Ursula Nestle · Heidelberg University9 papers (2017–2020)Roland Buhl · Johannes Gutenberg University Mainz8 papers (2017–2022)Jan Stratmann · National Institute of Genomic Medicine6 papers (2017–2020)Beatrice Wehler · Johannes Gutenberg University Mainz6 papers (2017–2020)Maria Blettner · Johannes Gutenberg University Mainz6 papers (2017–2020) · 6 papers (2017–2020)Hubert Wirtz · Berlin Institute of Health at Charité - Universitätsmedizin Berlin6 papers (2017–2020)Heinz Schmidberger · Johannes Gutenberg University Mainz5 papers (2017–2020)Martin Eichler · University Hospital Carl Gustav Carus5 papers (2017–2020) · 4 papers (2016–2017)Collin Jacobs · Johannes Gutenberg University Mainz4 papers (2014–2018)Thomas Wehler · Justus-Liebig-Universität Gießen4 papers (2017–2019)Mirjam Renovanz · University Children's Hospital Tübingen4 papers (2016–2017)Martin Sebastian · Goethe University Frankfurt4 papers (2017–2019)Anne‐Katrin Hickmann · LMU Klinikum4 papers (2016–2017)Mareile Janko · Johannes Gutenberg University Mainz4 papers (2016–2017)Jan Coburger · Washburn University4 papers (2016–2017)Karoline Kohlmann · Johannes Gutenberg University Mainz4 papers (2016–2017)Oliver Bayer · Johannes Gutenberg University Mainz3 papers (2020–2022)